FDA Reorganizes Its Office Of Cancer Drugs
Make a commentBy Ed Silverman // September 12th, 2011 // 10:36 am
• Pharma Blog » Archives
Richard Pazdur
FDA Officials Talk Tough About Accelerated Approval
2 CommentsBy Ed Silverman // March 28th, 2011 // 10:46 am
Should FDA Hit The Brakes On Accelerated Approval?
4 CommentsBy Ed Silverman // February 9th, 2011 // 9:06 am
Avastin Decision Not Based On Cost: FDA Official
6 CommentsBy Ed Silverman // January 7th, 2011 // 9:37 am
Provenge Activists Press Case For FDA Documents
6 CommentsBy Ed Silverman // October 8th, 2010 // 7:13 am
The Roche Breast Cancer Drug & The FDA Rejection
3 CommentsBy Ed Silverman // August 30th, 2010 // 9:26 am
FDA Panel Votes Down Avastin For Breast Cancer
5 CommentsBy Ed Silverman // July 20th, 2010 // 3:35 pm
The Mylotarg Withdrawal And Accelerated Approval
4 CommentsBy Ed Silverman // June 22nd, 2010 // 7:03 am
FDA Derides ‘Conspiracy Theory’ Over Provenge Delay
18 CommentsBy Ed Silverman // February 5th, 2010 // 9:33 am
Provenge Activists Fail To Get FDA Documents
21 CommentsBy Ed Silverman // December 2nd, 2008 // 9:03 am